Drug recall · December 16, 2015
MECLIZINE HYDROCHLORIDE TABLETS recall
Why: Failed Impurities/Degradation Specifications: Out of specification for impurities.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
MECLIZINE HYDROCHLORIDE TABLETS, 12.5 mg, Packaged in 1000 ct Bottles, Rx Only. Manufactured by: Par Pharmaceuticals Companies Inc., Spring Valley, NY 10977. Packaged by: GSMS Incorporated, Carmarillo, CA 93012. NDC: 60429-204-10.
- Lots / codes
Lot # GS007205 Expiry: Aug-17; Lot #:GS007344, Expiry: Aug-17; Lot #: GS008089, Expiry: Feb-18; Lot #: GS008842, Expiry: Feb-18; Lot #: GS009055, Expiry: Feb-18; Lot #: GS009131; Expiry: Feb-18.
- Quantity
- 1136 Bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- U.S. Nationwide
- Initiated
- November 25, 2015 · Voluntary: Firm initiated
- Classified
- December 4, 2015
- Reported
- December 16, 2015
- Ended
- June 7, 2016
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meclizine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.